Helptext

Movies



Company Information

Company NameEurocine Vaccines AB
Company Idea

Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs. The vaccines are developed up to proof of concept (clinical phase I/II) and licensed to partners for further development and commercialization. The company's proprietary vaccine adjuvant technologies, which are a key element of the nasal vaccines, are also offered to license partners for development in various indications.

Present focus is on partnering the nasal influenza vaccine program, Immunose™ FLU, which has shown proof of concept in a clinical study, and on preclinical development of a nasal vaccine against bacterial pneumonia.

Phone070-634 0171CEOHans Arwidsson
E-mailinfo(snabel-a)eurocine-vaccines(punkt)comChairm. of the BoardMichael Wolff Jensen
Homepagehttp://www.eurocine-vaccines.com 

Instrument Information

Full NameEurocine VaccinesShort NameEUCI
No of shares53,458,721Par Value0.11 SEK
TypeShareISIN codeSE0001839069

Price Information

+/-0.40
%9.88
Latest4.45
High4.77
Low3.90
Volume1,355,875
Turnover (SEK)5,913,040
Market Cap (MSEK)238

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume
5:29 PMAVANON4.45300
5:29 PMNONNON4.451,000
5:29 PMMLINON4.45474
5:29 PMMLINON4.452,000
5:29 PMMLIENS4.452,750
5:22 PMNONENS4.402,000
5:21 PMNONENS4.425,000
5:21 PMAVAENS4.42250
5:19 PMSWBNON4.51500
5:18 PMDDBNON4.51880

Scheduled Reports

DateReport
2017-11-18Delårsrapport ett
2017-12-14Årsstämma




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se